Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Semaglutide at a dose of 2.4 mg weekly is the first weekly long-acting GLP-1 RA approved for non-syndromic obesity treatment with a mean weight change of 14.9% in individuals with obesity without diabetes (39) and 9.6% in individuals with obesity and concomitant diabetes (40)
Take the same total weekly dose, split it into smaller amounts, inject more frequently, and reduce those brutal nausea spikes that hit a day or two after your full injection
If you take a GLP-1 and experience side effects that concern you, speak with your healthcare professional.
Saxenda EPAR product information
And if anything else comes up in questions, reach out to us
It is also an antioxidant, which helps cells fight damage from harmful compounds called free radicals
US$ 26.65
US$ 25.11
US$ 29.34
US$ 26.36
